Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Retained Earnings: 2018-2025

Historic Retained Earnings for Verastem (VSTM) over the last 8 years, with Sep 2025 value amounting to -$1.1 billion.

  • Verastem's Retained Earnings fell 27.06% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 27.06%. This contributed to the annual value of -$955.5 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Verastem's Retained Earnings stood at -$1.1 billion, which was down 9.53% from -$1.0 billion recorded in Q2 2025.
  • Verastem's 5-year Retained Earnings high stood at -$607.5 million for Q1 2021, and its period low was -$1.1 billion during Q3 2025.
  • Moreover, its 3-year median value for Retained Earnings was -$879.0 million (2024), whereas its average is -$907.4 million.
  • Data for Verastem's Retained Earnings shows a maximum YoY declined of 27.06% (in 2025) over the last 5 years.
  • Quarterly analysis of 5 years shows Verastem's Retained Earnings stood at -$663.7 million in 2021, then fell by 11.12% to -$737.5 million in 2022, then decreased by 10.66% to -$797.5 million in 2023, then fell by 11.72% to -$955.5 million in 2024, then decreased by 27.06% to -$1.1 billion in 2025.
  • Its Retained Earnings was -$1.1 billion in Q3 2025, compared to -$1.0 billion in Q2 2025 and -$1.0 billion in Q1 2025.